End-of-day quote
Korea S.E.
03:30:00 03/05/2024 am IST
|
5-day change
|
1st Jan Change
|
34,950
KRW
|
+0.58%
|
|
+1.75%
|
-8.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
5,32,810
|
6,68,301
|
5,64,513
|
3,44,828
|
4,55,944
|
4,14,980
|
-
|
Enterprise Value (EV)
2 |
512.6
|
702.4
|
536.7
|
344.8
|
455.9
|
456.3
|
457
|
P/E ratio
|
12.7
x
|
11
x
|
15.2
x
|
15.4
x
|
9.32
x
|
7.85
x
|
6.93
x
|
Yield
|
1.3%
|
0.97%
|
1.26%
|
2.06%
|
-
|
1.72%
|
1.72%
|
Capitalization / Revenue
|
1.46
x
|
1.64
x
|
1.29
x
|
0.7
x
|
0.83
x
|
0.67
x
|
0.61
x
|
EV / Revenue
|
1.4
x
|
1.73
x
|
1.23
x
|
0.7
x
|
0.83
x
|
0.74
x
|
0.67
x
|
EV / EBITDA
|
8.8
x
|
10.6
x
|
8.6
x
|
5.99
x
|
8.14
x
|
5.26
x
|
4.66
x
|
EV / FCF
|
22.4
x
|
79.9
x
|
-
|
-
|
-
|
13.4
x
|
9.93
x
|
FCF Yield
|
4.46%
|
1.25%
|
-
|
-
|
-
|
7.45%
|
10.1%
|
Price to Book
|
2.49
x
|
2.79
x
|
1.93
x
|
1.22
x
|
-
|
1.13
x
|
0.99
x
|
Nbr of stocks (in thousands)
|
11,939
|
11,895
|
11,835
|
11,829
|
11,874
|
11,874
|
-
|
Reference price
3 |
44,628
|
56,182
|
47,700
|
29,150
|
38,400
|
34,950
|
34,950
|
Announcement Date
|
11/03/20
|
15/02/21
|
16/02/22
|
14/02/23
|
20/03/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
365
|
406.7
|
436.9
|
492.4
|
552
|
619.6
|
681.2
|
EBITDA
1 |
58.23
|
65.95
|
62.45
|
57.6
|
56.02
|
86.75
|
98.15
|
EBIT
1 |
48.4
|
54.12
|
49.6
|
40.87
|
56
|
64.5
|
74
|
Operating Margin
|
13.26%
|
13.31%
|
11.35%
|
8.3%
|
10.15%
|
10.41%
|
10.86%
|
Earnings before Tax (EBT)
1 |
47.83
|
72.43
|
45.18
|
40.15
|
63.11
|
67.45
|
76.5
|
Net income
1 |
38.21
|
55.56
|
34.78
|
22.38
|
50.47
|
53.2
|
60.45
|
Net margin
|
10.47%
|
13.66%
|
7.96%
|
4.54%
|
9.14%
|
8.59%
|
8.87%
|
EPS
2 |
3,520
|
5,102
|
3,142
|
1,891
|
4,120
|
4,454
|
5,045
|
Free Cash Flow
3 |
22,863
|
8,789
|
-
|
-
|
-
|
34,000
|
46,000
|
FCF margin
|
6,263.58%
|
2,161.22%
|
-
|
-
|
-
|
5,487.85%
|
6,753.28%
|
FCF Conversion (EBITDA)
|
39,260.68%
|
13,326.09%
|
-
|
-
|
-
|
39,193.08%
|
46,867.04%
|
FCF Conversion (Net income)
|
59,840.63%
|
15,818.72%
|
-
|
-
|
-
|
63,909.77%
|
76,095.95%
|
Dividend per Share
2 |
578.5
|
545.5
|
600.0
|
600.0
|
-
|
600.0
|
600.0
|
Announcement Date
|
11/03/20
|
15/02/21
|
16/02/22
|
14/02/23
|
20/03/24
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
112.3
|
113.7
|
-
|
124.1
|
123.1
|
129.3
|
127.9
|
138.2
|
145.2
|
146
|
154.5
|
159.5
|
165.3
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
14.73
|
8.681
|
-
|
10.87
|
2.025
|
16.25
|
11.19
|
14.95
|
11.99
|
13.3
|
15.1
|
17.5
|
19
|
Operating Margin
|
13.13%
|
7.63%
|
-
|
8.76%
|
1.64%
|
12.56%
|
8.75%
|
10.82%
|
8.25%
|
9.11%
|
9.77%
|
10.97%
|
11.49%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
14.28
|
-
|
8.728
|
-
|
-
|
-
|
-
|
-
|
-
|
11.3
|
12.5
|
14.3
|
15.4
|
Net margin
|
12.72%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
7.74%
|
8.09%
|
8.97%
|
9.32%
|
EPS
|
-
|
-
|
717.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/11/21
|
16/02/22
|
16/05/22
|
09/08/22
|
04/11/22
|
14/02/23
|
04/05/23
|
14/11/23
|
20/03/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
34.1
|
-
|
-
|
-
|
41.3
|
42
|
Net Cash position
1 |
20.2
|
-
|
27.8
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.5165
x
|
-
|
-
|
-
|
0.4761
x
|
0.4279
x
|
Free Cash Flow
2 |
22,863
|
8,789
|
-
|
-
|
-
|
34,000
|
46,000
|
ROE (net income / shareholders' equity)
|
21.4%
|
25.7%
|
13.4%
|
8.16%
|
-
|
15.4%
|
15.2%
|
ROA (Net income/ Total Assets)
|
13.9%
|
15.8%
|
8.11%
|
4.92%
|
-
|
9.85%
|
10.2%
|
Assets
1 |
275.9
|
351.2
|
428.7
|
454.8
|
-
|
540.1
|
595.6
|
Book Value Per Share
3 |
17,920
|
20,170
|
24,733
|
23,874
|
-
|
31,021
|
35,471
|
Cash Flow per Share
3 |
-
|
4,246
|
-
|
-
|
-
|
6,470
|
7,389
|
Capex
1 |
19.3
|
37.7
|
40.7
|
41.3
|
-
|
36.2
|
38.5
|
Capex / Sales
|
5.28%
|
9.27%
|
9.31%
|
8.39%
|
-
|
5.84%
|
5.64%
|
Announcement Date
|
11/03/20
|
15/02/21
|
16/02/22
|
14/02/23
|
20/03/24
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
34,950
KRW Average target price
54,000
KRW Spread / Average Target +54.51% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.98% | 306M | | +21.85% | 546B | | -4.77% | 359B | | +16.97% | 323B | | +5.69% | 290B | | +13.68% | 234B | | +3.65% | 198B | | -11.12% | 194B | | +8.08% | 167B | | -3.40% | 157B |
Other Pharmaceuticals
|